Thryv Therapeutics Advances THRV-1268 in Long QT S...
Category : ODD/BTA/FTA Status 27 April 2026Fast Track status + Phase 2/3 dosing marks a critical inflection point. A small biotech just made a...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Addex & Neurosterix Push NTX-253 Toward Phase 1 Re...
Category : Clinical Trial Update 27 April 2026A quiet but important milestone is approaching in CNS drug development. Addex Therapeutics announced...
GE HealthCare Advances a Potential Gadolinium Alte...
Category : Clinical Trial Update 27 April 2026A long-standing dependency in medical imaging is finally being challenged. GE HealthCare has dosed t...
Belite Bio Moves Closer to First-Ever Stargardt Tr...
Category : Clinical Trial Update 24 April 2026Stargardt disease type 1 is not just rare. It is relentless. Typically begins in adolescence...
Roche’s Fenebrutinib Raises the Bar in Multiple Sc...
Category : Clinical Trial Update 24 April 2026For years, multiple sclerosis (MS) treatment has followed a trade-off: Oral drugs → conve...
Latest Newsletter Post
-
GE HealthCare Advances a Potential..
27 April 2026
-
Addex & Neurosterix Push NTX-253 To..
27 April 2026
-
Thryv Therapeutics Advances THRV-12..
27 April 2026
-
Spinogenix Advances First-in-Class..
24 April 2026
-
Roche’s Fenebrutinib Raises the Bar..
24 April 2026
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com